|Harvard economists Robert J. Barro
in Business Week, 16 July 2001:
"Moreover, it is probably a bad idea to take the profitability out of this business because any cure or vaccine for AIDS is likely to emerge from the efforts of profit-seeking corporations.
"Another problem is that the rigorous regiments the treatments require make questionable their effectiveness in low-income societies. If this is not enough, one also has to realize that to the extent the treatments were effective, the resulting increase in life spans could--since the medicines are not cures--actually expand the epidemic. I also mentioned that assistance might be more efficiently directed at measles and malaria, for which the dollar cost of saving a life is much lower."